Private Harbour Investment Management & Counsel, LLC Historic Quarter Change: Foreign Stocks, Reduced

Private Harbour Investment Management & Counsel, LLC historic quarter change: Foreign Stocks, Reduced

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 23 quarters from 2013-06-30 to 2026-06-30, Private Harbour Investment Management & Counsel, LLC opened 2 positions, added to 9, reduced 35 and sold out of 3.

Q1 2024: Stock ULXXXX; Country of operation —; Class SPON ADR NEW; Shares before 28,953.
Q3 2016: Stock NVS; Country of operation —; Class SPONSORED ADR; Shares before 31,948.
Q3 2016: Stock TEVA; Country of operation —; Class ADR; Shares before 9,970.
Q2 2016: Stock NVS; Country of operation —; Class SPONSORED ADR; Shares before 32,573.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1453526), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-04); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-04-30); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-10-28); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-12); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-04-23); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-12); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-10-16); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-08); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-04-11); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-07); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-01); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-09); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-09); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-10); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-10); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-14); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-10); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-12); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-12); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-08); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-10); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-12). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2010-03-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

Quarter	Stock	Country of operation	Class	Shares before	Shares after	Share change	Value before	Value after	Value change	Filed
Q1 2024	ULXXXX UNILEVER PLC		SPON ADR NEW	28,953	28,354	-599	$1,403,641	$1,423,087	+$19,446	2024-04-11
Q3 2016	NVS NOVARTIS A G		SPONSORED ADR	31,948	30,702	-1,246	$2,636,000	$2,424,000	-$212,000	2016-11-07
Q3 2016	TEVA TEVA PHARMACEUTICAL INDS LTD		ADR	9,970	8,970	-1,000	$501,000	$413,000	-$88,000	2016-11-07
Q2 2016	NVS NOVARTIS A G		SPONSORED ADR	32,573	31,948	-625	$2,360,000	$2,636,000	+$276,000	2016-08-01
Q2 2016	BP BP PLC		SPONSORED ADR	11,500	11,375	-125	$347,000	$404,000	+$57,000	2016-08-01
Q1 2016	NVS NOVARTIS A G		SPONSORED ADR	33,698	32,573	-1,125	$2,899,000	$2,360,000	-$539,000	2016-05-09
Q1 2016	TEVA TEVA PHARMACEUTICAL INDS LTD		ADR	10,470	9,970	-500	$687,000	$533,000	-$154,000	2016-05-09
Q4 2015	NVS NOVARTIS A G		SPONSORED ADR	36,893	33,698	-3,195	$3,392,000	$2,899,000	-$493,000	2016-02-09
Q4 2015	TEVA TEVA PHARMACEUTICAL INDS LTD		ADR	10,750	10,470	-280	$607,000	$687,000	+$80,000	2016-02-09
Q4 2015	BP BP PLC		SPONSORED ADR	13,550	11,500	-2,050	$414,000	$360,000	-$54,000	2016-02-09
Q4 2015	VALE VALE S A		ADR	20,725	20,525	-200	$87,000	$68,000	-$19,000	2016-02-09
Q3 2015	BP BP PLC		SPONSORED ADR	20,625	13,550	-7,075	$824,000	$414,000	-$410,000	2015-11-10
Q3 2015	NVS NOVARTIS A G		SPONSORED ADR	37,268	36,893	-375	$3,664,000	$3,392,000	-$272,000	2015-11-10
Q2 2015	TEVA TEVA PHARMACEUTICAL INDS LTD		ADR	10,945	10,750	-195	$681,000	$635,000	-$46,000	2015-08-10
Q2 2015	NVS NOVARTIS A G		SPONSORED ADR	37,443	37,268	-175	$3,692,000	$3,664,000	-$28,000	2015-08-10
Q2 2015	VALE VALE S A		ADR	20,775	20,725	-50	$117,000	$122,000	+$5,000	2015-08-10
Q1 2015	VALE VALE S A		ADR	22,675	20,775	-1,900	$186,000	$117,000	-$69,000	2015-05-14
Q1 2015	TEVA TEVA PHARMACEUTICAL INDS LTD		ADR	11,555	10,945	-610	$665,000	$681,000	+$16,000	2015-05-14
Q1 2015	BP BP PLC		SPONSORED ADR	20,150	19,450	-700	$768,000	$760,000	-$8,000	2015-05-14
Q4 2014	VALE VALE S A		ADR	78,575	22,675	-55,900	$865,000	$186,000	-$679,000	2015-02-10
Q4 2014	NVS NOVARTIS A G		SPONSORED ADR	39,882	36,933	-2,949	$3,754,000	$3,422,000	-$332,000	2015-02-10
Q4 2014	TEVA TEVA PHARMACEUTICAL INDS LTD		ADR	17,230	11,555	-5,675	$926,000	$665,000	-$261,000	2015-02-10
Q4 2014	BP BP PLC		SPONSORED ADR	20,175	20,150	-25	$887,000	$768,000	-$119,000	2015-02-10
Q3 2014	NVS NOVARTIS A G		SPONSORED ADR	39,919	39,882	-37	$3,614,000	$3,754,000	+$140,000	2014-11-12
Q3 2014	TEVA TEVA PHARMACEUTICAL INDS LTD		ADR	17,280	17,230	-50	$906,000	$926,000	+$20,000	2014-11-12
Q2 2014	NVS NOVARTIS A G		SPONSORED ADR	40,532	39,919	-613	$3,446,000	$3,614,000	+$168,000	2014-08-12
Q2 2014	TEVA TEVA PHARMACEUTICAL INDS LTD		ADR	18,280	17,280	-1,000	$966,000	$906,000	-$60,000	2014-08-12
Q2 2014	VALE VALE S A		ADR	78,825	78,300	-525	$1,090,000	$1,036,000	-$54,000	2014-08-12
Q1 2014	NVS NOVARTIS A G		SPONSORED ADR	41,409	40,532	-877	$3,328,000	$3,446,000	+$118,000	2014-05-08
Q4 2013	TEVA TEVA PHARMACEUTICAL INDS LTD		ADR	26,030	16,730	-9,300	$983,000	$671,000	-$312,000	2014-02-10
Q4 2013	CHKR CHESAPEAKE GRANITE WASH TR	United States	COM SH BEN INT	46,785	42,435	-4,350	$625,000	$450,000	-$175,000	2014-02-10
Q4 2013	NVS NOVARTIS A G		SPONSORED ADR	41,432	41,409	-23	$3,178,000	$3,328,000	+$150,000	2014-02-10
Q3 2013	NVS NOVARTIS A G		SPONSORED ADR	42,527	41,432	-1,095	$3,007,000	$3,178,000	+$171,000	2013-11-12
Q3 2013	CHKR CHESAPEAKE GRANITE WASH TR	United States	COM SH BEN INT	49,685	46,785	-2,900	$766,000	$625,000	-$141,000	2013-11-12
Q3 2013	TEVA TEVA PHARMACEUTICAL INDS LTD		ADR	28,383	26,030	-2,353	$1,113,000	$983,000	-$130,000	2013-11-12

Similar Firms

Firm Name	Country	13F Value	Holdings
Markin Asset Management, LP	United States	$0.091B	38
Spruce Point Capital Management, LLC	United States	$0.091B	24
Plus Group Wealth Advisors LLC	United States	$0.091B	41
ACCOUNT MANAGEMENT LLC	United States	$0.091B	23
Guilbault Capital LLC	United States	$0.091B	67
Miller Financial Services LLC	United States	$0.091B	125
MLP3, LLC	United States	$0.091B	86
Measured Risk Portfolios, Inc.	United States	$0.091B	68
Provident Living Financial Services, Inc.	United States	$0.091B	50
Incision Capital Management LP	United States	$0.091B	4